Stop Metronidazole and Switch to Rifaximin
You should stop metronidazole immediately and switch to rifaximin 550 mg twice daily for 1-2 weeks, as rifaximin is significantly more effective for SIBO with both hydrogen and methane production (60-80% efficacy) compared to metronidazole's documented lower efficacy. 1, 2
Why Rifaximin is Superior for Your Situation
Rifaximin is the most effective first-line treatment for SIBO with combined hydrogen and methane production, achieving 60-80% eradication rates in confirmed cases 1, 2
Metronidazole has documented lower efficacy for SIBO treatment and should not be first choice 1, 2
In direct comparison studies, rifaximin showed significantly higher SIBO decontamination rates (63.4%) versus metronidazole (43.7%) 3
For patients with both hydrogen and methane positivity specifically, rifaximin response rates reach 80%, compared to only 47.4% for hydrogen alone 4
The Resistance Concern is Not Applicable Here
Rifaximin demonstrates no clinically relevant bacterial resistance because it is not absorbed from the gastrointestinal tract, reducing systemic resistance risk 2, 5
The "finish antibiotics to prevent resistance" principle applies primarily to systemically absorbed antibiotics, not to rifaximin's unique non-absorbed mechanism 1
After only 2 doses of metronidazole, you have minimal risk of creating resistance by stopping—the greater concern is continuing an inferior treatment that is less likely to eradicate your SIBO 1, 3
Additional Treatment Considerations
Combined hydrogen and methane breath testing is more accurate than hydrogen-only testing for identifying your type of SIBO 1, 2
The standard rifaximin regimen is 550 mg twice daily for 1-2 weeks 1, 2, 4
Rifaximin has a significantly better safety profile with lower adverse events compared to metronidazole 5, 3
Important Safety Note About Metronidazole
Long-term metronidazole use carries risk of peripheral neuropathy—patients should stop immediately if numbness or tingling develops in feet 1, 2
While you've only taken 2 doses, this underscores why metronidazole is not the preferred agent for SIBO 1